Advances in multiple myeloma treatment over the last years
What is the best treatment in the next few years to achieve more treatment-free remission in CML?
Why do charities need to keep funding research into leukemia and blood cancer in general?
FLT3 inhibitors - their role in AML
COMy 2017: Day 1 discussion on progress in multiple myeloma, patient advocacy and drug costs
Arnon Nagler et al.